Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Middle East Pharmaceutical Industries Co Days Payable?
Middle East Pharmaceutical Industries CoSAU:4016 +0.92%22 Days Payable is 82.83 as of Mar. 2026, which is 10% above its 10-year median of 75.01. GuruFocus rates SAU:4016 with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 925 Drug Manufacturers companies, Middle East Pharmaceutical Industries Co ranks better than 50.27% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Middle East Pharmaceutical Industries Co Days Payable Chart
Middle East Pharmaceutical Industries Co Annual Data
Trend
Dec23
Dec24
Dec25
Days Payable
76.15
67.11
75.01
Middle East Pharmaceutical Industries Co Quarterly Data
SAU:4016 vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Middle East Pharmaceutical Industries Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Middle East Pharmaceutical Industries Co Days Payable vs Drug Manufacturers Industry
Middle East Pharmaceutical Industries Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Middle East Pharmaceutical Industries Co (SAU:4016) has a Days Payable of 82.83 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Middle East Pharmaceutical Industries Co and its competitors. This is 10% above median its historical median of 75.01. Over the past decade, Middle East Pharmaceutical Industries Co's Days Payable has ranged from 67.11 to 90.98. According to the industry distribution chart, Middle East Pharmaceutical Industries Co ranks #460 out of 925 companies in the Drug Manufacturers industry, placing it in the top 49.7%.
Is Middle East Pharmaceutical Industries Co's Days Payable too high?
Middle East Pharmaceutical Industries Co's current Days Payable of 82.83 is 10% above median its 10-year median of 75.01. Over the past 10 years, this metric has ranged from a low of 67.11 to a high of 90.98. The Drug Manufacturers industry median Days Payable is 90.38. Middle East Pharmaceutical Industries Co's value of 82.83 is 8.4% below this industry median. Based on the distribution chart, Middle East Pharmaceutical Industries Co ranks #460 out of 925 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Middle East Pharmaceutical Industries Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Middle East Pharmaceutical Industries Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Middle East Pharmaceutical Industries Co ranks #460 out of 925 companies for Days Payable. This puts Middle East Pharmaceutical Industries Co in the upper half of its industry. The industry median Days Payable is 90.38. Middle East Pharmaceutical Industries Co's value of 82.83 is 8.4% below this benchmark. Historically, Middle East Pharmaceutical Industries Co's own Days Payable has ranged from 67.11 to 90.98 over the past decade. While the company's 10-year median is 75.01 vs. the industry median of 90.38, Middle East Pharmaceutical Industries Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Middle East Pharmaceutical Industries Co's current Days Payable of 82.83 is 8.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Middle East Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Middle East Pharmaceutical Industries Co's current Days Payable is 82.83, which is 10% above median its own 10-year median of 75.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Pharmaceutical Industries Co stock overvalued right now?
Middle East Pharmaceutical Industries Co (SAU:4016) has a current Days Payable of 82.83. The current Days Payable is 82.83, which is 10% above median its 10-year median of 75.01 and 8.4% below the Drug Manufacturers industry median of 90.38. Middle East Pharmaceutical Industries Co's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Middle East Pharmaceutical Industries Co (SAU:4016), the current Days Payable is 82.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Middle East Pharmaceutical Industries Co Business Description
Middle East Pharmaceutical Industries Co is a holding company engaged in manufacturing medicines, medicated and non-medicated creams and gels. The company operates in Private, Public, and Export segments. Geographically, it generates the majority of its revenue from Saudi Arabia.
22GF Score
Get the complete analysis for SAU:4016
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4016 has been successfully added to your 
